Nanovis
Private Company
Total funding raised: $28M
Overview
Nanovis is a private, commercial-stage company that has developed a proprietary nanotechnology platform for implant surface enhancement. Its flagship nanoVIS Ti™ Surface Technology is integrated into spinal interbodies and pedicle screws, with regulatory clearances and a significant commercial partnership with Medtronic. The company operates as a B2B technology provider, licensing its surface treatments to original equipment manufacturers (OEMs) in the orthopedic and spinal sectors, positioning it in the growing market for advanced biomaterials.
Technology Platform
Proprietary nano-scale surface engineering technologies (nanoVIS Ti™ Surface Technology and Nanotube Technology) that create controlled topographies on implant materials (titanium, PEEK) to enhance protein adsorption, cell attachment, and bone ongrowth for improved implant integration and fixation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Nanovis competes in the advanced biomaterials surface treatment segment, facing competition from other surface technologies like traditional plasma spray, hydroxyapatite coatings, and alternative nano/micro-porous surfaces from companies like Zimmer Biomet (Trabecular Metal), 4WEB Medical, and others. Its differentiation lies in the specific nano-architecture of its proprietary surfaces and its regulatory designations as a nanotechnology.